Unveiling the Potential Impacts of Broadening the Definition of Women’s Health in Clinical Trials

In the second episode of our series on women’s health, we explore the potential impacts on clinical trial outcomes and how broadening the definition of women’s health can open up funding to address it. We delve into what may happen to future generations if women, who are the custodians of generational health, are not comfortable sharing complete medical histories. Hosted by Lori Ellis, Head of Insights at BioSpace, the episode features guests including Sans Thakur, Founder and Chairwoman of Tower Capital; Chia Chia Sun, Chief Commercial Officer at Fab Biopharma; Elisa Cascade, Chief Product Officer at Advarra; Shawana Moore, Medical Advisor on the Advisory Council for Healthy Women; and Katie Schubert, President and Chief Executive Officer of the Society for Women’s Health. Listeners can tune in to the podcast on Spotify, Apple Podcasts, Amazon Music, and iHeart Radio for an in-depth discussion on the importance of redefining women’s health and its potential benefits to future generations.